Zymeworks Common Stock Stock Price on September 11, 2024
| ZYME Stock | USD 14.09 0.33 2.29% |
Below is the normalized historical share price chart for Zymeworks Common Stock extending back to April 28, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Zymeworks Common stands at 14.09, as last reported on the 2nd of December, with the highest price reaching 14.55 and the lowest price hitting 14.04 during the day.
If you're considering investing in Zymeworks Stock, it is important to understand the factors that can impact its price. Zymeworks Common appears to be not too volatile, given 3 months investment horizon. Zymeworks Common Stock shows Sharpe Ratio of 0.12, which attests that the company had a 0.12% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Zymeworks Common Stock, which you can use to evaluate the volatility of the company. Please utilize Zymeworks Common's Mean Deviation of 2.03, downside deviation of 2.41, and Market Risk Adjusted Performance of 0.4007 to validate if our risk estimates are consistent with your expectations.
At present, Zymeworks Common's Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 149.4 M, whereas Common Stock is forecasted to decline to about 510.8 M. . As of December 2, 2024, Price To Sales Ratio is expected to decline to 8.94. In addition to that, Price Earnings Ratio is expected to decline to -6.33. Zymeworks Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 28th of April 2017 | 200 Day MA 11.024 | 50 Day MA 13.8711 | Beta 1.157 |
Zymeworks |
Sharpe Ratio = 0.1231
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ZYME | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.89 actual daily | 25 75% of assets are more volatile |
Expected Return
| 0.36 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Zymeworks Common is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Zymeworks Common by adding it to a well-diversified portfolio.
Price Book 2.6445 | Enterprise Value Ebitda 0.3383 | Price Sales 15.9683 | Shares Float 41.2 M | Wall Street Target Price 17.8556 |
Related Headline
Mersana Therapeutics Headline on 11th of September 2024
Acquisition by Huber Martin H. Jr. of 166750 shares of Mersa... by Huber Martin H. Jr.
Filed transaction by Mersana Therapeutics Director, Officer: President, Ceo. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Zymeworks Common Valuation on September 11, 2024
It is possible to determine the worth of Zymeworks Common on a given historical date. On September 11, 2024 Zymeworks was worth 11.96 at the beginning of the trading date compared to the closed value of 12.1. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Zymeworks Common stock. Still, in general, we apply an absolute valuation method to find Zymeworks Common's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Zymeworks Common where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Zymeworks Common's related companies.
| Open | High | Low | Close | Volume | |
| 11.67 | 12.10 | 11.67 | 12.03 | 321,012 | |
09/11/2024 | 11.96 | 12.38 | 11.94 | 12.10 | 1,199,800 |
| 12.10 | 12.28 | 11.93 | 12.18 | 319,361 |
| Backtest Zymeworks Common | | | Zymeworks Common History | | | Zymeworks Common Valuation | Previous | Next |
Zymeworks Common Trading Date Momentum on September 11, 2024
| On September 12 2024 Zymeworks Common Stock was traded for 12.18 at the closing time. The top price for the day was 12.28 and the lowest listed price was 11.93 . The trading volume for the day was 319.4 K. The trading history from September 12, 2024 was a factor to the next trading day price growth. The trading date delta against the next closing price was 0.66% . The trading date delta against the current closing price is 9.34% . |
Zymeworks Common Stock Fundamentals Correlations and Trends
By evaluating Zymeworks Common's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Zymeworks Common's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Zymeworks financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Zymeworks Common Stock history
Zymeworks Common investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Zymeworks is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Zymeworks Common Stock will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Zymeworks Common stock prices may prove useful in developing a viable investing in Zymeworks Common
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 68.9 M | 42.3 M | |
| Net Income Applicable To Common Shares | 111.9 M | 117.5 M |
Zymeworks Common Quarterly Net Working Capital |
|
Zymeworks Common Stock Technical Analysis
Zymeworks Common technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Zymeworks Common Period Price Range
Low | December 2, 2024
| High |
0.00 | 0.00 |
Zymeworks Common Stock cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Zymeworks Common December 2, 2024 Market Strength
Market strength indicators help investors to evaluate how Zymeworks Common stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Zymeworks Common shares will generate the highest return on investment. By undertsting and applying Zymeworks Common stock market strength indicators, traders can identify Zymeworks Common Stock entry and exit signals to maximize returns
Zymeworks Common Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Zymeworks Common's price direction in advance. Along with the technical and fundamental analysis of Zymeworks Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Zymeworks to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1042 | |||
| Jensen Alpha | 0.2384 | |||
| Total Risk Alpha | (0.13) | |||
| Sortino Ratio | 0.0938 | |||
| Treynor Ratio | 0.3907 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Zymeworks Stock analysis
When running Zymeworks Common's price analysis, check to measure Zymeworks Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zymeworks Common is operating at the current time. Most of Zymeworks Common's value examination focuses on studying past and present price action to predict the probability of Zymeworks Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zymeworks Common's price. Additionally, you may evaluate how the addition of Zymeworks Common to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |